Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Illumina Inc
(NQ:
ILMN
)
124.73
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Illumina Inc
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
March 16, 2022
SOURCE: Illumina
Via
3BL Media
Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India
March 15, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Named One of Fast Company's Most Innovative Companies for 2022
March 09, 2022
SOURCE: Illumina
Via
3BL Media
Celebrating Women's History Month: Illumina Spotlights Scientist Geraldine Pittman Woods
March 08, 2022
SOURCE: Illumina
Via
3BL Media
Illumina's Technology Supports Biodiversity and Conservation Initiatives
March 04, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Celebrates Rare Disease Day
March 01, 2022
SOURCE: Illumina
Via
3BL Media
“The World Expands”: Celebrating Rare Disease Day in Japan
February 24, 2022
SOURCE: Illumina
Via
3BL Media
African Coronavirus Surveillance Network Provides Early Warning for World
February 17, 2022
SOURCE: Illumina
Via
3BL Media
Exposures
COVID-19
From Patents to Patients: Meet the Women Making a Difference at Illumina
February 15, 2022
SOURCE: Illumina
Via
3BL Media
Topics
Intellectual Property
Exposures
Intellectual Property
Illumina to Support Neuro Genomics Project at McGill University
February 14, 2022
SOURCE: Illumina
Via
3BL Media
Illuminating Rare Disease: Get to Know SLC6A1 Connect
February 08, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Partners With Centers Across France to Advance a Precision Medicine Approach for Patients With Late-Stage Cancer
February 07, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Collaborates With National Cancer Center Japan to Address a Leading Cause of Death in Asia
February 04, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Earns Gold Class in the S&P Global's 2022 Sustainability Yearbook
February 03, 2022
SOURCE: Illumina
Via
3BL Media
Topics
Stocks
Exposures
US Equities
Promising Results Continue to Develop Optimism in Fight Against Cancers
January 27, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 27, 2021 – USA News Group – There’s plenty of optimism surrounding the major medical breakthroughs targeting multiple types...
Via
FinancialNewsMedia
Illumina's Diversity, Equity, and Inclusion Actions Earn External Recognition and Further Advance Our Culture of Care
January 27, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Grant Recipient Addresses Food Insecurities Through the Breeding of Yams
January 26, 2022
SOURCE: Illumina
Via
3BL Media
Multiplex Assays Market worth $4.3 billion by 2026 – Key Players are Illumina, Inc. (US), Luminex Corporation (US)
January 24, 2022
Via
AB Newswire
Illumina Collaborates With Nashville Biosciences to Accelerate Medicines Development
January 20, 2022
SOURCE: Illumina
Via
3BL Media
Illumina's Nonprofit Partner Future Kings Is Cultivating the Next Generation of STEM Leaders
January 19, 2022
SOURCE: Illumina
Via
3BL Media
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
January 18, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Named One of America's Most JUST Companies for Third Consecutive Year
January 13, 2022
SOURCE: Illumina
Via
3BL Media
Promising Developments in Breast Cancer Treatments Ahead in 2022
January 12, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 12, 2022 – USA News Group – So far in 2022, there have already been some impressive developments in the battle against...
Via
FinancialNewsMedia
Illumina Partners With Agendia to Expand Genomic Testing in Breast Cancer Care
January 12, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Announces New Innovative Partnerships, Along With New Groundbreaking Technologies at 2022 J.P. Morgan Healthcare Conference
January 11, 2022
SOURCE: Illumina
Via
3BL Media
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
January 10, 2022
From
Agendia, Inc.
Via
Business Wire
Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri® Multi-Cancer Early Detection Test
January 10, 2022
From
GRAIL, LLC
Via
Business Wire
GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test
January 10, 2022
From
GRAIL, LLC
Via
Business Wire
Illumina Donates Over $14 Million to Local Communities and Volunteers More Than 6,000 Hours in 2021
January 07, 2022
SOURCE: Illumina
Via
3BL Media
Illumina Enters Co-Development Partnership with SomaLogic to Help Researchers’ Understanding of Biology and Disease
January 06, 2022
SOURCE: Illumina
Via
3BL Media
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.